financetom
Business
financetom
/
Business
/
Trump releases AI policy to pre-empt state rules
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump releases AI policy to pre-empt state rules
Mar 20, 2026 5:58 AM

WASHINGTON, March 20 (Reuters) - The White House released a framework on artificial intelligence on Friday that aims to ensure protections for children, communities and small businesses as part of a national plan to regulate developments in the field.

The Trump administration has been pushing for a single legislative framework that can be applied uniformly across the country, rather than leaving states to form their own plans.

U.S. President Donald Trump in December said he would withhold federal broadband funding from states whose laws to regulate artificial intelligence are judged by his administration to be holding back American dominance in the technology.

"The administration looks forward to working with Congress in the coming months to turn this framework into legislation that the president can sign," the White House said in a statement.

The framework calls on Congress to streamline permitting so electricity-gobbling data centers can generate their own power on site. It wants to increase the federal government's ability to fight AI-generated scams and national security concerns.

The plan calls for removing barriers to innovation, accelerating AI deployment across business sectors and making it easier to build top-grade AI systems.

Protections for children include giving parents controls of accounts and devices to protect their children's privacy and supports features to combat potential sexual exploitation or self-harm.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Joint Finalizes Sale of 31 Clinics in Arizona, New Mexico
Joint Finalizes Sale of 31 Clinics in Arizona, New Mexico
Jul 7, 2025
08:07 AM EDT, 07/07/2025 (MT Newswires) -- Joint (JYNT) said Monday it completed the sale of 31 clinics and associated franchise licenses in Arizona and New Mexico to its largest franchisee Joint Ventures. The sale price included $8.3 million in cash and regional developer rights for the Northwest region, which generated $855,000 in royalties and franchise fees over a 12-month...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Surge Copper Announces $6.4 Million Equity Financing to Support Progress to Pre-Feasibility and EA Readiness at Berg
Surge Copper Announces $6.4 Million Equity Financing to Support Progress to Pre-Feasibility and EA Readiness at Berg
Jul 7, 2025
08:11 AM EDT, 07/07/2025 (MT Newswires) -- Surge Copper ( SRGXF ) on Monday said it will raise up to $6.4 million in a non-brokered equity offering to support the development at its flagship Berg Project. The Offering is anchored by strong participation from existing shareholders, including a strategic investor increasing its ownership to up to 19.9%, said the company....
Lexeo Therapeutics Says FDA Granted Breakthrough Therapy Designation for Potential Drug for Friedreich's Ataxia
Lexeo Therapeutics Says FDA Granted Breakthrough Therapy Designation for Potential Drug for Friedreich's Ataxia
Jul 7, 2025
08:12 AM EDT, 07/07/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Monday the US Food and Drug Administration has granted breakthrough therapy designation to LX2006, the company's gene therapy candidate for Friedreich's ataxia, a rare and progressive neurodegenerative disease. The designation was based on interim clinical data showing meaningful improvements in both cardiac and neurologic function. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved